COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis

Fabrizio Fabrizi1, Carlo M Alfieri1,2, Roberta Cerutti1

  • 1Division of Nephrology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.

Insights

Acute kidney injury (AKI) is a frequent complication in hospitalized COVID-19 patients, affecting 15.4% of cases. Older age and hypertension increase AKI risk, which is significantly higher in deceased patients.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic with significant morbidity and mortality.
  • Preliminary evidence indicates acute kidney injury (AKI) is an uncommon but serious complication in COVID-19 patients.
  • AKI in COVID-19 is associated with poorer patient outcomes, necessitating further investigation.

Purpose of the Study:

  • To systematically review and meta-analyze clinical studies on the frequency of AKI in hospitalized COVID-19 patients.
  • To evaluate the incidence of AKI and the requirement for renal replacement therapy (RRT) in this population.
  • To assess the relationship between AKI and mortality risk in COVID-19 patients.

Main Methods:

  • A systematic literature review and meta-analysis of clinical studies were performed.
  • Data from 39 studies encompassing 25,566 unique COVID-19 patients were analyzed.
  • The DerSimonian and Laird random-effects model was used, incorporating heterogeneity and stratified analyses.

Main Results:

  • The pooled incidence of AKI across studies was 15.4% (95% CI, 10.7%-20.1%), with significant heterogeneity observed.
  • The overall frequency of RRT in COVID-19 patients was 4.3% (95% CI, 3.1%-5.5%).
  • AKI incidence was higher in severe COVID-19 cases (53%) and strongly associated with mortality (OR 15.4). Age and arterial hypertension were identified as risk factors for AKI.

Conclusions:

  • Acute kidney injury (AKI) is a common and significant complication in hospitalized patients with COVID-19.
  • The findings highlight the increased risk of AKI and its association with mortality in this patient group.
  • Further research is warranted to elucidate the mechanisms of kidney injury in COVID-19 and to develop targeted interventions.
Abstract

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
568
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
300
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
148
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
469
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
138
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
203